
J&J boosts planned US manufacturing investment to $55B
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johnson & Johnson is planning
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johnson & Johnson is planning
EQS Newswire / 21/03/2025 / 22:00 UTC+8 Guru Club, March 12丨TOT BIOPHARM – B (1875.HK) announced that for the full-year results ending December 31, 2024,
EQS-News: Heidelberg Pharma AG / Key word(s): Annual Report Heidelberg Pharma announces financial figures and reports on successful business performance in 2024 21.03.2025 / 07:07
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Smiths Medical, now part of
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: DispatchHealth and Medically Home have
Morning! Today, we have plenty of interesting content from yesterday’s STAT Breakthrough Summit East in New York. Also, Alnylam wins an important approval for ATTR-CM.
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s
As basketball fans anxiously checked March Madness scores on Thursday, scientists met in Manhattan at the STAT Breakthrough Summit East to enter a Big Dance
What a joy to see and meet so many of you yesterday at STAT Breakthrough East in New York City! A huge thanks to our